Craft

Medtronic

Stock Price

$90.3

2024-10-29

Market Capitalization

$114.6 B

2024-08-26

Revenue

$32.4 B

FY, 2024

Medtronic Summary

Company Summary

Overview
Medtronic is a company that specializes in healthcare technologies and therapies. It operates in four segments: Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes implantable devices, leads, and delivery systems, products for the treatment of atrial fibrillation, devices for the repair and replacement of heart valves, coronary stents, and other products. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, airway, ventilation, inhalation therapy products, etc. The Neuroscience Portfolio segment provides platform technologies, implant therapies, biologic solutions, pelvic health and neurovascular products, and other solutions. The Diabetes Operating Unit segment delivers insulin pumps and consumables, continuous glucose monitoring systems and sensors, infusion sets, etc.
Type
Public
Status
Active
Founded
1949
HQ
Galway, IE | view all locations
Website
https://www.medtronic.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Scott Cundy

    Scott Cundy, SVP & Chief Quality Officer

  • Matt Walter

    Matt Walter, Chief Human Resources Officer

  • Ken Washington

    Ken Washington, SVP & Chief Technology and Innovation Officer

  • Ivan Fong

    Ivan Fong, EVP, General Counsel & Secretary

Operating MetricsView all

Countries

150

FY, 2023

Floor Space, square feet

9.8M
2.1%

FY, 2023

Patients

74M
2.6%

FY, 2023

LocationsView all

112 locations detected

  • Galway, G HQ

    Ireland

    Building 2 Parkmore Business Park West

  • Boulder, CO

    United States

    6135 Gunbarrel Ave

  • Danvers, MA

    United States

    35 Cherry Hill Dr

  • Doral, FL

    United States

    9850 NW 41st St #450

  • Eatontown, NJ

    United States

    51 James Way

  • Fridley, MN

    United States

    7000 Central Ave NE

and 106 others

Medtronic Financials

Summary Financials

Revenue (Q2, 2025)
$8.4B
Gross profit (Q2, 2025)
$5.5B
Net income (Q2, 2025)
$1.3B
Cash (Q2, 2025)
$1.4B
EBIT (Q2, 2025)
$1.6B
Enterprise value
$141.5B

Footer menu